BAYER AG |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 27.45 EUR | +0.51% |
|
+5.67% | -18.05% |
| Apr. 22 | European Equities Close Higher in Monday Trading; EC Probes TikTok Over Possible DSA Violations | MT |
| Apr. 22 | JPMorgan rates Bayer at 'Neutral' - Target 34 euros | DP |
| Sales 2024 * | 47.22B 50.49B | Sales 2025 * | 48.14B 51.48B | Capitalization | 26.83B 28.69B |
|---|---|---|---|---|---|
| Net income 2024 * | 2.23B 2.38B | Net income 2025 * | 3.16B 3.38B | EV / Sales 2024 * | 1.26 x |
| Net Debt 2024 * | 32.69B 34.95B | Net Debt 2025 * | 29.48B 31.52B | EV / Sales 2025 * | 1.17 x |
| P/E ratio 2024 * |
12.5
x | P/E ratio 2025 * |
8.41
x | Employees | 96,931 |
| Yield 2024 * |
0.4% | Yield 2025 * |
0.88% | Free-Float | 99.97% |
More Fundamentals
* Assessed data
More news
Latest transcript on Bayer AG
More press releases
More news
| 1 day | +0.42% | ||
| 1 week | +5.46% | ||
| Current month | -3.25% | ||
| 1 month | +2.48% | ||
| 3 months | -15.42% | ||
| 6 months | -32.89% | ||
| Current year | -18.21% |
1 week
25.61
27.70
1 month
25.6128.94
Current year
24.9636.09
1 year
24.9660.81
3 years
24.9667.99
5 years
24.9678.34
10 years
24.96146.45
| Managers | Title | Age | Since |
|---|---|---|---|
William Anderson
CEO | Chief Executive Officer | 57 | 23-03-31 |
| Director of Finance/CFO | 54 | 18-04-25 | |
Bijoy Sagar
CTO | Chief Tech/Sci/R&D Officer | 55 | 20-03-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Colleen Goggins
BRD | Director/Board Member | 68 | 17-03-31 |
| Director/Board Member | 68 | 17-03-31 | |
Alberto Weisser
BRD | Director/Board Member | 67 | 21-03-31 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 9.77% | 70 M€ | -.--% | - | |
| 5.71% | 2 M€ | +13.56% | - | |
| 4.28% | 962 M€ | -.--% | - | |
| 4.10% | 0 M€ | 0.00% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-23 | 27.55 | +0.86% | 309 382 |
| 24-04-22 | 27.32 | +3.76% | 4,999,901 |
| 24-04-19 | 26.32 | +0.32% | 4,224,860 |
| 24-04-18 | 26.24 | -0.04% | 2,759,804 |
| 24-04-17 | 26.25 | +0.65% | 2,359,047 |
Delayed Quote Xetra, April 23, 2024 at 03:31 am EDT
More quotes
Bayer AG is one of the world's leaders in designing, producing, and marketing pharmaceutical products and agrochemicals. Net sales are distributed by product family as follows:
- agrochemicals (48.8%): herbicides, fungicides, insecticides, etc.;
- pharmaceutical products (38%): intended for the prevention and treatment of cardiovascular and respiratory diseases, diabetes, nervous system disorders, etc.;
- OTC products and nutritional supplements (12.7%);
- other (0.5%).
Net sales are distributed geographically as follows: Germany (5.1%), Switzerland (1.2%), Europe-Middle East-Africa (23.2%), the United States (30.6%), North America (3.5%), China (7.6%), Asia-Pacific (10%), Brazil (10.4%) and Latin America (8.4%).
Sector
Pharmaceuticals
Calendar
2024-04-26
- Annual General Meeting
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B-
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
21
Last Close Price
27.32
EUR
Average target price
37.05
EUR
Spread / Average Target
+35.63%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -18.21% | 28.56B | |
| +25.46% | 659B | |
| +25.34% | 557B | |
| -4.86% | 359B | |
| +16.44% | 322B | |
| +8.34% | 297B | |
| +6.55% | 215B | |
| +7.79% | 210B | |
| -6.75% | 200B | |
| -8.79% | 149B |
- Stock Market
- Equities
- BAYN Stock
